Cargando…
Serial viral load analysis by DDPCR to evaluate FNC efficacy and safety in the treatment of mild cases of COVID-19
INTRODUCTION: The SARS-CoV-2 outbreak has threatened the human population globally as the numbers of reinfection cases even after large-scale vaccination. Trials have been carried out to find drugs effective in fighting the disease, as COVID-19 is being considered a treatable disease only after we h...
Autores principales: | da Silva, Renato Martins, Gebe Abreu Cabral, Paula, de Souza, Sávio Bastos, Arruda, Raul Ferraz, Cabral, Sheila Passos de Figueiredo, de Assis, Arícia Leone Evangelista Monteiro, Martins, Yolanda Porto Muniz, Tavares, Carlos Augusto de Araújo, Viana Junior, Antônio Brazil, Chang, Junbiao, Lei, Pingsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053779/ https://www.ncbi.nlm.nih.gov/pubmed/37007788 http://dx.doi.org/10.3389/fmed.2023.1143485 |
Ejemplares similares
-
Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients
por: de Souza, Sávio Bastos, et al.
Publicado: (2023) -
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
por: Yu, Bin, et al.
Publicado: (2020) -
FNC efficiently inhibits mantle cell lymphoma growth
por: Zhang, Yan, et al.
Publicado: (2017) -
The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses
por: Xu, Na, et al.
Publicado: (2020) -
FNC: An Advanced Anticancer Therapeutic or Just an Underdog?
por: Fayzullina, Daria, et al.
Publicado: (2022)